Page 4 - Us Fda

US regulators lift in-person restrictions on abortion pills

The Food and Drug Administration is loosening some restrictions on where women can obtain abortion pills, including a long-standing requirement that the medication be picked up in person

Market wrap: Benchmarks end lower for a second day; Sensex slips 166 pts

NBFCs to come under the ambit of PCA framework from Oct 2022; Anand Rathi Wealth debuts at 9% premium; WPI-based inflation hits 12-year high of 14.2% in Nov

Lupin surges 10% on good volumes after getting EIR from USFDA for Goa plant

Despite of today's gain, the stock has underperformed the market by falling 18 per cent in past six months, as compared to 10.5 per cent rally in the S&P BSE Sensex

US FDA okays AstraZeneca's Covid antibody cocktail for immunocompromised

The US Food and Drug Administration (FDA) has granted emergency use authorisation to AstraZeneca's monoclonal antibody treatment for Covid-19 among people with weakened immune systems.

More US states offering boosters amid fears of Covid resurgence in winters

California made the first move to expand access. Within days, officials in Colorado, New Mexico, Arkansas, West Virginia and New York City endorsed boosters for all adults

FDA plans to authorise Pfizer boosters for adults this week: Report

The Food and Drug Administration is aiming to authorise booster doses of Pfizer-BioNTech's coronavirus vaccine for all adults as early as Thursday

Joe Biden picks senior Google Health advisor Robert Califf as FDA chief

US President Joe Biden has picked senior Google Health advisor Dr Robert Califf as next chief of the Food and Drug Administration

Travellers fully vaccinated with Covaxin can enter US from Nov 8

The last-minute addition comes less than one week before the US launches its new travel system, granting entry to travellers who have received a vaccine that has been approved by the FDA or WHO.

Covid-19 vaccine for younger kids showed strong results, says Moderna

Health officials are aiming to get immunizations to younger children before the holiday season, when travel and indoor activity can bring an increased risk of infection

US FDA says Pfizer Covid-19 vaccine looks effective for young kids

Federal health regulators said late Friday that kid-size doses of Pfizer's COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children

Pfizer says its Covid vaccine is 91% effective in kids of ages 5 to 11

The efficacy result is based on a trial of about 2,250 children, according to the briefing documents

US FDA clears Moderna, J&J booster shots; backs Covid-19 vaccine mixing

Pfizer and BioNTech said a booster shot of their Covid-19 vaccine restored full protection in a large study, results that are likely to bolster the argument for giving a third dose more widely

FDA panel takes up tough questions on J&J Covid-19 boosters

U.S. health advisers on Friday tackled who should get boosters of Johnson & Johnson's single-shot COVID-19 vaccine and when - and whether using a competing brand for the second dose might provide better protection. The push for boosters kicked off last month after the Food and Drug Administration authorized third doses of the Pfizer vaccine for seniors and younger adults with health problems, jobs or living conditions that place them at higher risk from the coronavirus. On Thursday, an FDA advisory panel unanimously recommended a half-dose booster of the similar Moderna vaccine for the same groups. Friday, the same panel discussed a booster of J&J's vaccine but the decision is more complex. Moderna and Pfizer asked the FDA to OK boosters at least six months after immunization, but J&J proposed a sliding schedule with an extra dose as early as two months later. Adding another twist, the experts also will discuss preliminary data from a government mix-and-match study that ...

US FDA to evaluate J&J, Moderna Covid booster jabs this week

The US Food and Drug Administration is expected to evaluate the efficacy of Moderna and Johnson & Johnson's third dose of Covid vaccines this week.

A step from Covid-19 pills as Merck & Co seeks FDA approval

An application was submitted with the Food and Drug Administration for molnupiravir to treat mild-to-moderate Covid-19 in adults at risk of developing a severe illness that may require hospitalization

J&J seeks FDA's approval for Covid-19 vaccine booster shot in adults

If authorized, J&J's booster could give millions more Americans additional protection against the coronavirus

FDA approves older, Covid at-risk people for Pfizer booster shot in US

Booster doses can be given any time at least six months after a person received their second shot, says the agency.

Health officials back US FDA panel's decision on Covid booster shot

US health officials have voiced their support for the recommendation from the Food and Drug Administration (FDA) advisory panel that Covid-19 booster shots be limited to those 65 years and older

US FDA panel backs booster shot for elderly, high risk groups

A US FDA advisory panel has endorsed a booster shot of Pfizer-BioNTech Covid-19 vaccine six months after full inoculation in people above 65 years and for individuals at high risk for severe disease

FDA panel is first key test for Biden administration's Covid booster plan

A government advisory panel met to decide whether to endorse extra doses of the Pfizer vaccine